Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SHE:300357)
China
· Delayed Price · Currency is CNY 25.87
-0.06 (-0.23%)
Apr 29, 2026, 3:04 PM CST
SHE:300357 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 847.05 | 797.22 | 1,119 | 1,171 | 840.69 | 649.99 | Upgrade
|
| Short-Term Investments | - | 74.58 | - | - | - | - | Upgrade
|
| Trading Asset Securities | 478 | 560.23 | 196.09 | 117.39 | 295.05 | 370.93 | Upgrade
|
| Cash & Short-Term Investments | 1,325 | 1,432 | 1,315 | 1,289 | 1,136 | 1,021 | Upgrade
|
| Cash Growth | 3.02% | 8.91% | 2.03% | 13.47% | 11.25% | 14.62% | Upgrade
|
| Accounts Receivable | 295.26 | 242.93 | 251.04 | 202.92 | 254.31 | 238.12 | Upgrade
|
| Other Receivables | 6.92 | - | - | - | 19.81 | 11.13 | Upgrade
|
| Receivables | 302.18 | 242.93 | 251.04 | 202.92 | 274.12 | 249.26 | Upgrade
|
| Inventory | 53.68 | 54.76 | 57.73 | 59.04 | 48.41 | 53.75 | Upgrade
|
| Other Current Assets | 83.51 | 31.53 | 27.78 | 19.17 | 18.86 | 17.58 | Upgrade
|
| Total Current Assets | 1,764 | 1,761 | 1,651 | 1,570 | 1,477 | 1,342 | Upgrade
|
| Property, Plant & Equipment | 752.08 | 842.85 | 780.09 | 704.84 | 444.61 | 301.62 | Upgrade
|
| Long-Term Investments | 252.86 | 108.32 | 77.94 | 74.21 | 78.4 | 83.35 | Upgrade
|
| Other Intangible Assets | 126.59 | 149.46 | 162.79 | 161.38 | 139.67 | 94 | Upgrade
|
| Long-Term Deferred Tax Assets | 6.2 | 5.58 | 5.6 | 5.03 | 4.87 | 5.81 | Upgrade
|
| Long-Term Deferred Charges | 29.54 | 26.31 | 25.27 | 34.38 | 53.2 | 86.05 | Upgrade
|
| Other Long-Term Assets | 4.58 | 3.64 | 5.94 | 12.42 | - | 19.63 | Upgrade
|
| Total Assets | 2,936 | 2,897 | 2,709 | 2,562 | 2,198 | 1,932 | Upgrade
|
| Accounts Payable | 14.42 | 31.41 | 47.77 | 7.99 | 7.68 | 5.08 | Upgrade
|
| Accrued Expenses | 20.27 | 37.27 | 35.13 | 33.57 | 29.89 | 35.54 | Upgrade
|
| Short-Term Debt | 5 | 5 | 12.63 | 34.39 | - | - | Upgrade
|
| Current Portion of Leases | 4.18 | 4.08 | 5.03 | 6.8 | 3.98 | 5.86 | Upgrade
|
| Current Income Taxes Payable | 16.33 | 1.98 | 10.56 | 9.26 | 26.08 | 50.32 | Upgrade
|
| Current Unearned Revenue | 0.64 | 0.53 | 0.51 | 0.38 | 0.42 | 0.42 | Upgrade
|
| Other Current Liabilities | 6.67 | 64.3 | 70.95 | 84.64 | 34.71 | 10.78 | Upgrade
|
| Total Current Liabilities | 67.51 | 144.57 | 182.58 | 177.04 | 102.75 | 108 | Upgrade
|
| Long-Term Leases | 10.24 | 9.32 | 7.93 | 21.26 | 12.28 | 1.95 | Upgrade
|
| Long-Term Unearned Revenue | 31.27 | 31.74 | 33.53 | 30.93 | 27.43 | 24.91 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.02 | 0.03 | 0.17 | 0.2 | 0.08 | 0.5 | Upgrade
|
| Other Long-Term Liabilities | - | - | 26.08 | 29.03 | 28.22 | - | Upgrade
|
| Total Liabilities | 109.04 | 185.67 | 250.3 | 258.46 | 170.76 | 135.36 | Upgrade
|
| Common Stock | 523.58 | 523.58 | 523.58 | 523.58 | 523.58 | 523.58 | Upgrade
|
| Additional Paid-In Capital | 128.19 | 128.19 | 128.19 | 128.19 | 128.19 | 128.19 | Upgrade
|
| Retained Earnings | 2,087 | 1,968 | 1,702 | 1,533 | 1,328 | 1,084 | Upgrade
|
| Comprehensive Income & Other | 0.02 | 0.03 | 0.04 | 0.03 | 0.03 | 0 | Upgrade
|
| Total Common Equity | 2,739 | 2,619 | 2,354 | 2,185 | 1,980 | 1,736 | Upgrade
|
| Minority Interest | 88.55 | 92.27 | 105.12 | 118.61 | 47.49 | 60.54 | Upgrade
|
| Shareholders' Equity | 2,827 | 2,712 | 2,459 | 2,304 | 2,027 | 1,797 | Upgrade
|
| Total Liabilities & Equity | 2,936 | 2,897 | 2,709 | 2,562 | 2,198 | 1,932 | Upgrade
|
| Total Debt | 19.43 | 18.41 | 25.59 | 62.44 | 16.26 | 7.81 | Upgrade
|
| Net Cash (Debt) | 1,306 | 1,414 | 1,289 | 1,226 | 1,119 | 1,013 | Upgrade
|
| Net Cash Growth | 2.34% | 9.64% | 5.14% | 9.54% | 10.50% | 13.74% | Upgrade
|
| Net Cash Per Share | 2.49 | 2.70 | 2.46 | 2.34 | 2.14 | 1.93 | Upgrade
|
| Filing Date Shares Outstanding | 523.58 | 523.58 | 523.58 | 523.58 | 523.58 | 523.58 | Upgrade
|
| Total Common Shares Outstanding | 523.58 | 523.58 | 523.58 | 523.58 | 523.58 | 523.58 | Upgrade
|
| Working Capital | 1,697 | 1,617 | 1,469 | 1,393 | 1,374 | 1,234 | Upgrade
|
| Book Value Per Share | 5.23 | 5.00 | 4.50 | 4.17 | 3.78 | 3.32 | Upgrade
|
| Tangible Book Value | 2,612 | 2,470 | 2,191 | 2,024 | 1,840 | 1,642 | Upgrade
|
| Tangible Book Value Per Share | 4.99 | 4.72 | 4.18 | 3.87 | 3.51 | 3.14 | Upgrade
|
| Buildings | - | 638.01 | 428.52 | 423.31 | 175.67 | 137.89 | Upgrade
|
| Machinery | - | 168.95 | 135.42 | 115.99 | 95.51 | 77.11 | Upgrade
|
| Construction In Progress | - | 175.46 | 323.16 | 227.86 | 226.24 | 140.33 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.